去甲肾上腺素与5-羟色胺之间涉及血小板聚集的相互作用[会议论文集] - Suppr | 超能文献

Interactions between noradrenaline and 5-hydroxytryptamine involving platelet aggregation [proceedings].

作者信息

Ball S E, Boullin D J, Glenton P A

出版信息

J Physiol. 1977 Oct;272(1):98P-99P.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Interactions between noradrenaline and 5-hydroxytryptamine involving platelet aggregation [proceedings].去甲肾上腺素与5-羟色胺之间涉及血小板聚集的相互作用[会议论文集]

J Physiol. 1977 Oct;272(1):98P-99P.

2

The comparison between ADP-induced aggregation and noradrenaline plus 5-hydroxytryptamine induced aggregation.二磷酸腺苷（ADP）诱导的聚集与去甲肾上腺素加5-羟色胺诱导的聚集之间的比较。

Fukushima J Med Sci. 1978 Feb;25(1-2):1-7.

3

Mutual potentiation between noradrenaline and 5-hydroxytryptamine in producing aggregation of canine platelets.去甲肾上腺素与5-羟色胺在诱导犬血小板聚集过程中的相互增强作用。

Nihon Ketsueki Gakkai Zasshi. 1975 Jun;38(3):292-8.

4

Proceedings: Time-dependent potentiation and inhibition by 5-hydroxytryptamine of platelet aggregation induced by ADP.论文集：5-羟色胺对ADP诱导的血小板聚集的时间依赖性增强和抑制作用

Br J Pharmacol. 1975 Jun;54(2):221P-222P.

5

5-hydroxytryptamine and platelet aggregation.5-羟色胺与血小板聚集

Fed Proc. 1983 Feb;42(2):228-32.

6

A nucleotide with characteristic platelet aggregation and inhibition properties similar to 5-hydroxytryptamine [proceedings].一种具有与5-羟色胺相似的特征性血小板聚集和抑制特性的核苷酸[会议记录]

Br J Pharmacol. 1979 May;66(1):94P.

7

Changes in platelet aggregatory responses to collagen and 5-hydroxytryptamine in depressed, schizophrenic and manic patients.抑郁症、精神分裂症和躁狂症患者血小板对胶原蛋白和5-羟色胺聚集反应的变化。

Int Clin Psychopharmacol. 1992 Nov;7(2):81-5.

8

Proceedings: Human blood platelet aggregation induced by dopamine, 5-hydroxyptrypamine and analogues.

J Physiol. 1975 Nov;252(2):46P-47P.

9

[Kinetic analysis of induced platelet aggregation].[诱导血小板聚集的动力学分析]

Farmakol Toksikol. 1981 Sep-Oct;44(5):576-82.

10

Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.5-羟色胺受体阻断剂对5-羟色胺增强的人血小板聚集的抑制作用。

Biomed Biochim Acta. 1984;43(2):215-20.

引用本文的文献

1

Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.酮色林（R 41,468），一种选择性5-HT2受体拮抗剂，对5-羟色胺诱导和增强的人血小板聚集的抑制作用。1982年。

Agents Actions. 1994 Dec;43(3-4):225-34. doi: 10.1007/BF01986694.

2

Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.酮色林（R 41 468），一种选择性5-HT2受体拮抗剂，对5-羟色胺诱导和增强的人血小板聚集的抑制作用。

Agents Actions. 1982 Jul;12(3):388-97. doi: 10.1007/BF01965409.

3

Platelet shape change in patients with psychiatric disorders and treated with phenothiazines, thioxanthines, butyrophenones, benzodiazepines, tricyclic antidepressants and beta-adrenergic blocking agents.患有精神疾病并接受吩噻嗪类、硫杂蒽类、丁酰苯类、苯二氮䓬类、三环类抗抑郁药和β-肾上腺素能阻滞剂治疗的患者的血小板形状变化。

J Neural Transm. 1981;51(3-4):245-56. doi: 10.1007/BF01248956.

4

A nucleotide with characteristic platelet aggregation and inhibition properties similar to 5-hydroxytryptamine [proceedings].一种具有与5-羟色胺相似的特征性血小板聚集和抑制特性的核苷酸[会议记录]

Br J Pharmacol. 1979 May;66(1):94P.